Skip to main content

TableĀ 2 Comparison of gestational complications and neonatal conditions(n = 958)

From: Evaluating pregnancy outcomes in women with uterine fibroids treated with high-intensity focused ultrasound: insights from a single-institution study

Ā 

GroupI(n = 170)

Group II(n = 510)

Group III(n = 278)

P1-value

P2-value

Hemorrhage at delivery(ml)

335.47 ± 67.79

253.78 ± 93.60

337.12 ± 179.16

 < 0.05

 > 0.05

Postpartum hemorrhage

8(4.71)

9(1.76)

17(6.12)

 > 0.05

 > 0.05

Precipitate labour

0

21(4.12)

0

 < 0.05

/

Premature rupture of fetal membranes

32(18.82)

115(22.55)

4(1.44)

 > 0.05

 < 0.05

Gestational diabetes mellitus

14(8.24)

107(20.98)

58(20.86)

 < 0.05

 < 0.05

Hypertensive disorders in pregnancy

4(2.35)

8(1.57)

2(0.72)

 > 0.05

 > 0.05

Intrahepatic cholestasis of pregnancy

0

11(2.16)

11(3.86)

 > 0.05

 < 0.05

Threatened rupture of uterus

0

0

3(1.08)

/

 > 0.05

Incomplete uterine rupture

8(4.71)

0

31(11.15)

 < 0.05

 < 0.05

Hypothyroidism and Hashimoto's thyroiditis

20(11.76)

61(11.96)

40(14.39)

 > 0.05

 > 0.05

Hyperthyroidism

0

1(0.20)

11(3.96)

 > 0.05

 < 0.05

Cooley's anemia

0

20(3.92)

20(7.19)

 < 0.05

 < 0.05

Mild anemia

53(31.18)

87(17.06)

67(24.10)

 < 0.05

 > 0.05

Moderate anemia

8(4.71)

66(12.94)

46(16.55)

 < 0.05

 < 0.05

Thrombocytopenia

21(12.35)

59(11.57)

39(14.03)

 > 0.05

 > 0.05

Chorioamnionitis

0

2(0.39)

0

 > 0.05

/

Chorioamnionitis

0

2(0.39)

18(6.47)

 > 0.05

 < 0.05

Fetal growth restriction

0

2(0.39)

0

 > 0.05

/

Prethrombotic state

0

4(0.78)

2(0.72)

 > 0.05

 > 0.05

Sail placenta and racket placenta

0

10(1.96)

19(6.83)

 > 0.05

 < 0.05

PAS

18(10.59)

21(4.12)

40(14.39)

 < 0.05

 > 0.05

Mazischesis

0

1(0.20)

0

 > 0.05

/

Placental abruption

0

1(0.20)

2(0.72)

 > 0.05

 > 0.05

Uterine inertia

0

1(0.20)

/

 > 0.05

/

Prolonged latency

0

1(0.20)

/

 > 0.05

/

Fetal distress

0

2(0.39)

1(0.36)

 > 0.05

 > 0.05

Neonatal length(cm)

49.47 ± 0.81

49.72 ± 1.92

49.66 ± 1.46

 < 0.05

 > 0.05

Neonatal weight(g)

3209.53 ± 387.67

3319.06 ± 460.88

3361.33 ± 392.80

 < 0.05

 < 0.05

Fetal macrosomia

8(4.71)

32(6.27)

22(7.92)

 > 0.05

 > 0.05

Low birth weight infant

0

29(5.69)

1(0.36)

 < 0.05

 > 0.05

VLBWI

0

0

0

/

/

Asphyxia neonatorum

2(1.18)

7(1.37)

3(1.08)

 > 0.05

 > 0.05

Neonatal deformity

1(0.59)

5(0.98)

5(1.80)

 > 0.05

 > 0.05

  1. Data was described as mean ± SD or n (%)
  2. P1: Group I compared with Group II
  3. P2: Group I compared with Group III
  4. PAS:Placenta Accreta Spectrum Disorders, refers to conditions in the placenta accreta spectrum, including placenta accreta, increta, and percreta, in contrast to retained placenta
  5. Group I: HIFU-treated fibroid patients, Group II: Vaginal delivery patients without fibroids, Group III: Cesarean section patients without fibroids